全文获取类型
收费全文 | 1879篇 |
免费 | 117篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 82篇 |
妇产科学 | 75篇 |
基础医学 | 200篇 |
口腔科学 | 35篇 |
临床医学 | 217篇 |
内科学 | 296篇 |
皮肤病学 | 12篇 |
神经病学 | 259篇 |
特种医学 | 122篇 |
外科学 | 289篇 |
综合类 | 60篇 |
预防医学 | 98篇 |
眼科学 | 44篇 |
药学 | 82篇 |
肿瘤学 | 75篇 |
出版年
2022年 | 12篇 |
2021年 | 39篇 |
2020年 | 21篇 |
2019年 | 29篇 |
2018年 | 44篇 |
2017年 | 28篇 |
2016年 | 26篇 |
2015年 | 26篇 |
2014年 | 58篇 |
2013年 | 70篇 |
2012年 | 84篇 |
2011年 | 81篇 |
2010年 | 75篇 |
2009年 | 72篇 |
2008年 | 80篇 |
2007年 | 73篇 |
2006年 | 84篇 |
2005年 | 74篇 |
2004年 | 99篇 |
2003年 | 70篇 |
2002年 | 71篇 |
2001年 | 43篇 |
2000年 | 51篇 |
1999年 | 49篇 |
1998年 | 38篇 |
1997年 | 32篇 |
1996年 | 34篇 |
1995年 | 37篇 |
1994年 | 21篇 |
1993年 | 10篇 |
1992年 | 30篇 |
1991年 | 20篇 |
1990年 | 25篇 |
1989年 | 42篇 |
1988年 | 34篇 |
1987年 | 34篇 |
1986年 | 30篇 |
1985年 | 26篇 |
1984年 | 22篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 18篇 |
1980年 | 14篇 |
1979年 | 9篇 |
1978年 | 10篇 |
1977年 | 10篇 |
1975年 | 14篇 |
1974年 | 13篇 |
1973年 | 12篇 |
1972年 | 8篇 |
排序方式: 共有2002条查询结果,搜索用时 62 毫秒
51.
52.
53.
54.
55.
Kelsie Adkisson Katherine C. Cunningham Eric A. Dedert Michelle F. Dennis Patrick S. Calhoun Eric B. Elbogen 《Archives of Suicide Research》2013,17(4):678-687
The objective of the present study was to use retrospective data to test the hypothesis that cannabis dependence would be associated with an increased rate of post-deployment suicide attempts. Participants included 319 veterans who had deployed to either Iraq or Afghanistan. Study procedures involved completion of a structured clinical interview and a battery of self-report questionnaires. As expected, lifetime cannabis dependence was significantly associated with post-deployment suicide attempts, AOR = 7.963, p = .014, even after controlling for the effects of pre-deployment suicide attempts, posttraumatic stress disorder, depression, pain, non-cannabis substance use disorder, and gender. Although preliminary, our findings provide the first evidence to date that heavy cannabis use may be a unique risk factor for post-deployment suicide attempts among veterans. 相似文献
56.
Glioblastoma muhiforme (GBM) is a highly invasive brain tumour that is unvaryingly fatal in humans clesplte even aggres- sive therapeutic approaches such as surgical resection followed by chemotherapy and radiotherapy. Unconventional treatment options such as gene therapy provide an intriguing option for curbing glioma related deaths. To date, gene therapy has yielded encouraging results in preclinical animal models as well as promising safety profiles in phase I clinical trials, but has failed to demonstrate significant therapeutic efficacy in phase III clinical trials. The most widely studied antiglioma gene therapy strategies are suicide gene therapy, genetic immuno- therapy and oncolytic virotherapy, and we have attributed the challenging transition of these modalities into the clinic to four major road- blocks : ( 1 ) anatomical features of the central nervous system, (2) the host immune system, (3) heterogeneity and invasiveness of GBM and (4) limitations in current GBM animal models. In this review, we discuss possible ways to jump these hurdles and develop new gene therapies that may be used alone or in synergy with other modalities to provide a powerful treatment option for patients with GBM. 相似文献
57.
Gierisch JM Bastian LA Calhoun PS McDuffie JR Williams JW 《Journal of general internal medicine》2012,27(3):351-360
OBJECTIVES
We conducted a systematic literature review of smoking cessation interventions for patients with histories of depressive disorders or current significant depressive symptoms. We examined the comparative effectiveness of smoking cessation strategies on abstinence rates, differential effects of cessation strategies by depression status (i.e., history positive vs. current depression), and differential effects by gender. 相似文献58.
Obstructive sleep apnoea (OSA) and hypertension commonly coexist. Observational studies indicate that untreated OSA is strongly associated with an increased risk of prevalent hypertension, whereas prospective studies of normotensive cohorts suggest that OSA may increase the risk of incident hypertension. Randomized evaluations of continuous positive airway pressure (CPAP) indicate an overall modest effect on blood pressure (BP). Determining why OSA is so strongly linked to having hypertension in cross-sectional studies, but yet CPAP therapy has limited BP benefit needs further exploration. The CPAP studies do, however, indicate a wide variation in the BP effects of CPAP, with some patients manifesting a large antihypertensive benefit such that a meaningful BP effect can be anticipated in some individuals. OSA is particularly common in patients with resistant hypertension (RHTN). The reason for this high prevalence of OSA is not fully explained, but data suggest that it may be related to the high occurrence of hyperaldosteronism in patients with RHTN. In patients with RHTN, it has been shown that aldosterone levels correlate with severity of OSA and that blockade of aldosterone reduces the severity of OSA. Overall, these findings are consistent with aldosterone excess contributing to worsening of underlying OSA. We hypothesize that aldosterone excess worsens OSA by promoting accumulation of fluid within the neck, which then contributes to increased upper airway resistance. 相似文献
59.
Acelajado MC Pisoni R Dudenbostel T Dell'Italia LJ Cartmill F Zhang B Cofield SS Oparil S Calhoun DA 《Journal of clinical hypertension (Greenwich, Conn.)》2012,14(1):7-12
Among patients with resistant hypertension (RHTN), there are those whose blood pressure (BP) remains uncontrolled in spite of maximal medical therapy. This retrospective analysis aims to characterize these patients with refractory hypertension. Refractory hypertension was defined as BP that remained uncontrolled after ≥3 visits to a hypertension clinic within a minimum 6-month follow-up period. Of the 304 patients referred for RHTN, 29 (9.5%) remained refractory to treatment. Patients with refractory hypertension and those with controlled RHTN had similar aldosterone levels and plasma renin activity (PRA). Patients with refractory hypertension had higher baseline BP (175±23/97±15 mm Hg vs 158±25/89±15 mm Hg; P=.001/.005) and heart rate, and higher rates of prior stroke and congestive heart failure. During follow-up, the BP of patients with refractory hypertension remained uncontrolled (168.4±14.8/93.8±17.7 mm Hg) in spite of use of an average of 6 antihypertensive medications, while those of patients with controlled RHTN decreased to 129.3±11.2/77.6±10.8 mm Hg. Spironolactone reduced the BP by 12.9±17.8/6.6±13.7 mm Hg in patients with refractory hypertension and by 24.1±16.7/9.2±12.0 mm Hg in patients with controlled RHTN. In patients with RHTN, approximately 10% remain refractory to treatment. Similar aldosterone and PRA levels and a diminished response to spironolactone suggest that aldosterone excess does not explain the treatment failure. 相似文献
60.
RR Pillai R Divekar A Brasier S Bhavnani WJ Calhoun 《Current allergy and asthma reports》2012,12(5):388-395
Asthma is a chronic inflammatory disease of the airways that leads to various degrees of recurrent respiratory symptoms affecting patients globally. Specific subgroups of asthma patients have severe disease leading to increased healthcare costs and socioeconomic burden. Despite the overwhelming prevalence of the asthma, there are limitations in predicting response to therapy and identifying patients who are at increased risk of morbidity. This syndrome presents with common clinical signs and symptoms; however, awareness of subgroups of asthma patients with distinct characteristics has surfaced in recent years. Investigators attempt to describe the phenotypes of asthma to ultimately assist with diagnostic and therapeutic applications. Approaches to asthma phenotyping are multifold; however, it can be partitioned into 2 essential groups, clinical phenotyping and molecular phenotyping. Innovative techniques such as bipartite network analysis and visual analytics introduce a new dimension of data analysis to identify underlying mechanistic pathways. 相似文献